Pharus Diagnostics

Zhubei City, Taiwan · Founded 2022 · Privately Held (backing)

Developer and provider of liquid biopsy tests intended for the early detection of cancer. Pharus Diagnostics is based in Zhubei City, Taiwan and was founded in 2022. Its last reported valuation was $43 million in Apr 2025. It has raised $17.1 million.

Last reported valuation
$43.0M
Oct 2026
Priced at
—
Total raised
$17.1M
Last round
—

Who backs Pharus Diagnostics?

5 investors
InvestorType
Lee Family OfficeFamily office
CK Hutchison—
CK Life Sciences International—
Larta Institute—
QuarkBio—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Pharus Diagnostics investors

5 investors are on record for Pharus Diagnostics, including Lee Family Office, CK Hutchison, CK Life Sciences International and Larta Institute.

Free account
More of Pharus Diagnostics with a free account
  • ·Watch Pharus Diagnostics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 5 firms already write checks for companies like Pharus Diagnostics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View